How Big is the Heart Pump Market | Trends & Share 2031

What is the size of Heart Pump Market?

Heart pump market is continued to grow in the upcoming years, driven by the increasing incidence of end-stage heart failure, advancements in pump technologies, and rising adoption of mechanical circulatory support devices.

Key Growth Drivers of the Heart Pump Market

• Increasing use of minimally invasive cardiac support solutions
• Favourable reimbursement policies and government-funded cardiac programs
• Rising prevalence of advanced heart failure cases and limited heart transplant availability
• Technological advancements in ventricular assist devices (VADs) and total artificial hearts
• Improving patient survival rates and quality of life through mechanical support systems

Heart Pump Market Trends

Heart pump market is undergoing for the transformation with notable trends such as rising shift towards the compact, durable, and fully implantable VADs. Further, the magnetically levitated and centrifugal pumps are gaining traction for their reduced complication rates. Aside from these, the trend of wearable controller systems and remote monitoring technologies are becoming more common, enhancing the outpatient care and patient mobility.

Emerging Developments in the Heart Pump Market

Heart pump market is experiencing the development with biocompatible and wireless energy transfer technologies, reducing driveline infections. Now, the companies are also working on next-generation total artificial hearts. Alongside, hybrid heart pump systems that offer adaptive flow control is emerging in the market. Smart pump integration with patient apps and AI-based monitoring tools is a rising trend.

List of Leading Companies in the Heart Pump Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. Abbott Laboratories

This company produces the HeartMate ventricular assist devices widely used for patients with advanced heart failure and bridging to transplant.

2. Medtronic plc

This company develops heart pump systems including extracorporeal and percutaneous VADs for short- and long-term cardiac support.

3. Abiomed, Inc.

This company offers the Impella heart pump platform, a minimally invasive percutaneous device used for high-risk PCI and cardiogenic shock treatment.

4. Berlin Heart GmbH

This company specializes in mechanical circulatory support systems such as EXCOR® VAD for paediatric and adult patients with terminal heart failure.

5. SynCardia Systems, LLC

This company manufactures the Total Artificial Heart system for end-stage heart failure patients not eligible for VADs or transplantation.

6. Jarvik Heart, Inc.

This company is especially focusing on developing long-term implantable VADs like the Jarvik 2000® designed to support heart function in chronic heart failure.

7. ReliantHeart Inc.

This company produces the aVAD heart pump with wireless monitoring and advanced flow control features for enhanced patient outcomes.

8. Evaheart, Inc.

This company offers implantable left ventricular assist devices designed with advanced suspension mechanisms to reduce haemolysis and thrombosis.

How Big is the Heart Pump Market: FAQs